Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1134031 | 0.74 | — | — | |
| SCHEMBL453463 | 0.74 | — | — | |
| SCHEMBL7086942 | 0.74 | ALOX15 (0.32) | — | |
| SCHEMBL17375347 | 0.72 | ALDH1A1 (0.32) | FFAR3TSHRALDH1A1KDM4CKCNN4 | |
| SCHEMBL10547847 | 0.72 | ALDH1A1 (0.36) | FFAR3TSHRALDH1A1KDM4CKCNN4 | |
| Hydrochloric Acid SCHEMBL22987133 | 0.72 | KDM4C (0.43) | FFAR3TSHRALDH1A1KDM4CKCNN4 | |
| SCHEMBL10799052 | 0.72 | — | — | |
| SCHEMBL22628822 | 0.71 | TET2 (0.33) | TSHRALDH1A1KDM4CCYP2D6CYP2C19 | |
| SCHEMBL22487745 | 0.70 | FFAR3 (0.30) | FFAR3 | |
| SCHEMBL28936457 | 0.70 | ALDH1A1 (0.35) | FFAR3TSHRALDH1A1MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346980-A1 | TAIL-CONJUGATED RNAS | TIBA BIOTECH (US) | 2023-11-02 | — | — | US | disclosed |
| WO-2023212213-A1 | TAIL-CONJUGATED RNAS | TIBA BIOTECH (US) | 2023-11-02 | — | — | WO | disclosed |
| US-8969551-B2 | Morpholino nucleic acid derivatives | NIPPON SHINYAKU CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-20130197220-A1 | Morpholino Nucleic Acid Derivatives | NIPPON SHINYAKU CO., LTD. (JP) | 2013-08-01 | — | — | US | disclosed |
| US-8101655-B2 | Fluorescent dyes and complexes | SMITH GERALD ARTHUR (GB) | 2012-01-24 | — | — | US | disclosed |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-10-07 | — | — | US | disclosed |
| US-7674918-B2 | Fluorescent dyes and complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| US-20070238884-A1 | Fluorescent Dyes and Complexes | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| EP-1740947-A2 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2007-01-10 | — | — | EP | disclosed |
| US-6994960-B1 | Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2006-02-07 | — | — | US | disclosed |
| WO-2005098437-A2 | FLUORESCENT DYES AND COMPLEXES | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD (GB) | 2005-10-20 | — | — | WO | disclosed |
| EP-0985148-A4 | NUCLEIC ACID DIAGNOSTICS BASED ON MASS SPECTROMETRY OR MASS SEPARATION AND BASE SPECIFIC CLEAVAGE | INST MEDICAL W & E HALL (AU) | 2004-03-10 | — | — | EP | disclosed |
| EP-0985148-A1 | NUCLEIC ACID DIAGNOSTICS BASED ON MASS SPECTROMETRY OR MASS SEPARATION AND BASE SPECIFIC CLEAVAGE | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2000-03-15 | — | — | EP | disclosed |
| WO-1998054571-A1 | NUCLEIC ACID DIAGNOSTICS BASED ON MASS SPECTROMETRY OR MASS SEPARATION AND BASE SPECIFIC CLEAVAGE | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 1998-12-03 | — | — | WO | disclosed |
| EP-0477791-B1 | Polypeptide | ISHIHARA SANGYO KAISHA (JP) | 1996-08-07 | — | — | EP | disclosed |
| EP-0479071-B1 | Polypeptide | ISHIHARA SANGYO KAISHA (JP) | 1996-07-03 | — | — | EP | disclosed |
| US-5519119-A | TUMOR NECROSIS FACTOR POLYPEPTIDES AS ANTITUMOR AGENTS | ISHIHARA SANGYO KAISHA LTD. (JP) | 1996-05-21 | — | — | US | disclosed |
| US-5247070-A | N-TERMINAL MUTEINS OF TUMOR NECROSIS FACTOR | ISHIHARA SANGYO KAISHA LTD. (JP) | 1993-09-21 | — | — | US | disclosed |
| EP-0479071-A2 | Polypeptide | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1992-04-08 | — | — | EP | disclosed |
| EP-0477791-A2 | Polypeptide | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1992-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238884-A1 | Fluorescent Dyes and Complexes | F12, PYM1, ANXA6 | FFAR3 857/4885TSHR 1099/4885ALDH1A1 1039/4885 |
| US-20130197220-A1 | Morpholino Nucleic Acid Derivatives | MORF4L1, METTL16, METTL3 | FFAR3 3537/4885TSHR 1047/4885ALDH1A1 2942/4885 |
| US-20100256399-A1 | FLUORESCENT DYES AND COMPLEXES | F12, ANXA6, PYM1 | FFAR3 1126/4885TSHR 1171/4885ALDH1A1 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.